BiotechTube

esomeprazole 40 mg

Pre-clinicalCompleted
0 watching 0 views this week💤 Quiet
23
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

GERD

Conditions

GERD

Trial Timeline

Jul 1, 2008 → Mar 1, 2011

NCT ID
NCT01079884

About esomeprazole 40 mg

esomeprazole 40 mg is a pre-clinical stage product being developed by Johnson & Johnson for GERD. The current trial status is completed. This product is registered under clinical trial identifier NCT01079884. Target conditions include GERD.

Hype Score Breakdown

Clinical
5
Activity
2
Company
10
Novelty
2
Community
1

Clinical Trials (1)

NCT IDPhaseStatus
NCT01079884Pre-clinicalCompleted

Competing Products

20 competing products in GERD

See all competitors
ProductCompanyStageHype Score
Rabeprazole ER + RanitidineEisaiPhase 3
77
Rabeprazole sodiumEisaiPhase 1
33
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
77
rabeprazole sodium + PlaceboEisaiPhase 3
77
Rabeprazole ER + RanitidineEisaiPhase 3
77
Rabeprazole sodium 5 mg + Rabeprazole sodium 10 mgEisaiPhase 1
33
rabeprazole + rabeprazoleEisaiPhase 3
77
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
77
Rabeprazole sodium + EsomeprazoleEisaiPhase 3
77
ONO-8539Ono PharmaceuticalPhase 1
33
esomeprazole (Nexium®) + Xolaam®AstraZenecaApproved
85
esomeprazoleAstraZenecaPre-clinical
23
EsomeprazoleAstraZenecaApproved
85
EsomeprazoleAstraZenecaApproved
85
esomeprazole magnesiumAstraZenecaPhase 1
33
EsomeprazoleAstraZenecaApproved
85
EsomeprazoleAstraZenecaPhase 3
77
Esomeprazole (Nexium)AstraZenecaApproved
85
OmeprazoleAstraZenecaPhase 3
77
Open Label Run In Esomeprazole + Double Blind Esomeprazole + Double Blind PlaceboAstraZenecaPhase 3
77

Other Products from Johnson & Johnson

Fentanyl transdermal therapeutic systemApproved
85
Nicotine Gum + Nicotine PatchApproved
85
galantamineApproved
85
IbrutinibApproved
85
Paliperidone ERApproved
85